Call Options Transactions Made in Q2 2025 in Madrigal Pharmaceuticals, Inc. (MDGL)
This table provides information about the institutional ownership of Madrigal Pharmaceuticals, Inc. (MDGL) during Q2 2025. The information is specifically focused on institutions that hold call options of MADRIGAL PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Jane Street Group, LLC
New York, NY |
BUY
|
CALL |
36.9K+ 13.51% |
$9.87M - $12.6M
|
310K
$111M
|
|
|
Aug 14, 2025
Q2 2025
|
Barclays PLC
London, X0 |
BUY
|
CALL |
13.9KNew |
$3.72M - $4.74M
|
13.9K
$4.99M
|
|
|
Aug 14, 2025
Q2 2025
|
Nomura Holdings Inc
Tokyo, M0 |
BUY
|
CALL |
8.1KNew |
$2.17M - $2.76M
|
8.1K
$2.91M
|
|
|
Aug 14, 2025
Q2 2025
|
Squarepoint Ops LLC
New York, NY |
BUY
|
CALL |
800+ 38.1% |
$214K - $273K
|
2.9K
$1.04M
|
|
|
Aug 14, 2025
Q2 2025
|
Paul Tudor Jones
Tudor Investment Corp Et Al | Stamford, Ct
|
BUY
|
CALL |
800+ 72.73% |
$214K - $273K
|
1.9K
$682K
|
|
|
Aug 14, 2025
Q2 2025
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
CALL |
700+ 3.13% |
$187K - $239K
|
23.1K
$8.29M
|
|
|
Aug 13, 2025
Q2 2025
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
CALL |
-300- 42.86% |
$80.3K - $102K
|
400
$144K
|
|
|
Aug 14, 2025
Q2 2025
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
CALL |
-500- 15.63% |
$134K - $170K
|
2.7K
$969K
|
|
|
Aug 14, 2025
Q2 2025
|
Sig Brokerage, LP
Bala Cynwyd, PA |
SELL
|
CALL |
-3K- 54.55% |
$803K - $1.02M
|
2.5K
$898K
|
|
|
Aug 11, 2025
Q2 2025
|
Citigroup Inc
|
SELL
|
CALL |
-13.5K- 33.75% |
$3.61M - $4.6M
|
26.5K
$9.51M
|
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-20.7K- 30.22% |
$5.54M - $7.05M
|
47.8K
$17.2M
|
|
|
Aug 14, 2025
Q2 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
CALL |
-110K- 59.89% |
$29.3M - $37.4M
|
73.4K
$26.4M
|
|
|
Aug 14, 2025
Q2 2025
|
Armistice Capital, LLC
New York, NY |
SELL
|
CALL |
-130K- 43.33% |
$34.8M - $44.3M
|
170K
$61M
|